The most commonly reported effects include: Nausea the most common, typically peaks in the first 48 weeks and decreases significantly as the body adjusts Reduced appetite expected and intentional
The GLP-1 component is a great way to manage type 2 diabetes but is also highly effective as a weight loss treatment
The SURPASS-1 trial investigated the efficacy and safety of the three doses of 5, 10, or 15 mg tirzepatide in drug-nave patients with T2D who were not sufficiently controlled with a lifestyle intervention with diet and exercise versus placebo (70)
Seek emergency care for: Chest pain Passing out Severe shortness of breath What Your Clinician May Check And Why A clinician will review your history and medications, check vital signs, and may obtain an ECG to look at the rhythm
Using the Wrong Liquid As mentioned previously, only use the diluent provided or recommended by the pharmacy
Patients taking GLP-1 therapy often have underlying conditions such as obesity and diabetes that independently increase thrombotic risk